Please enable JavaScript.
Coggle requires JavaScript to display documents.
Thermo Fisher Scientific (Biotech & development) (Political / legal…
Thermo Fisher Scientific (Biotech & development)
Political / legal
abiding by laws of countries with whom they trade
consumer protection - are the drugs manufactured government approved?
data protection act 1998 - for both customer and employees
pollution, waste, disposal
patent licensing and drug manufacturing - barriers to entry (requirement to obtain license to operate
taxes and subsidies
NHS
Price Regulation -- Rationale and Effects
The high rate of entry to the pharmaceutical-biotechnology industry indicates that it is structurally competitive
Economic
changes in GDP - the total value of goods produced and services provided in a country during one year - affects risk tolerance of investors and pricing policies
currency fluctuations - affects on exports of goods
level of taxation - NHS and universities as customers receive goods tax free - less profit for business
Technological
online conferencing
telecummuting
email
advancing R&D
information transparency - increased monitoring / control
greater ability to trade faster and higher volumes and more precise
Social and Demographic
health trends
epidemics (zica virus)
education - graduate programme in R&D for employees of thermo
market segments - products for beauty / health
fat loss pills equipment
stakeholders - social / environmental reporting - carbon footprint - green products